Disc Disease
11
3
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
Predictors of Clinical Response After Interlaminar Cervical Epidural Steroid Injection for Cervical Radiculopathy
Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment
Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF
Pilot Study of ZetaFuse™ Bone Graft for the Treatment of Cervical Degenerative Disc Disease
The Effectiveness of Lumber Regression Technique on Disc Bulge Randomized Control Trial
Fibrin for Chronic Multi-level Discogenic Low Back Pain
Bone Marrow Concentrate (BMC) Injection in Intervertebral Discs
Galeazzi Spine Surgery RegistryGaleazzi Spine Registry: Prospective Study for Clinical Monitoring
Retrospective Study on the Evaluation of Intra-disc Infiltration in the Active Disc Disease
Epidural Steroid Following Discectomy for Herniated Disc Reduces Morbidity
Outcome After Lumbar Epidural Steroid Injection